A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
Investigated for use/treatment in benign prostatic hyperplasia, endometriosis, and prostate cancer.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.